Cambridge Healthtech Institute’s 2nd Annual

Safety and Efficacy of Multispecific Antibodies, ADCs, and Combination Therapies

Enhancing Safety and Creating Synergies for Novel Therapeutic Modalities

5 November 2024

As the next generation of multispecific therapies, antibody-drug conjugates, and combination therapies continues to develop, there is a growing focus on ensuring the safety and efficacy of these therapies. Safety and toxicity pose unique challenges among different therapeutic modalities. At Cambridge Healthtech Institute's 2^nd annual Safety and Efficacy of Multispecific Antibodies, ADCs, and Combination Therapies conference, sessions will build upon past and present research to explore the field is addressing these challenges. The conference will compare and contrast different therapeutic modalities, and speakers from industry, academia, and the clinic will go over strategies for mitigating toxicity, managing combination therapies, reducing side effects, and closing disparities in access. This meeting will complement topics in multispecific antibody discovery and engineering for meeting unmet clinical needs.

Coverage will include, but is not limited to:

Reviewing safety and efficacy profiles of emerging therapies
Addressing safety challenges and strategies for mitigating toxicity risks
Optimising therapies with biomarker selection and companion diagnostics
Creating synergies with combination therapies and avoiding overlapping toxicities
Clinical management of adverse effects
Predicting molecular mechanisms of toxicities such as ICANS
Defining dose escalation recommendations
Improving efficacy in the face of safety challenges
Comparing differences in bispecific antibodies, multispecific antibodies, ADCs, CAR T bispecifics, immune cell engagers, and combination therapies
Strategic target-based therapeutic development
Novel and non-antibody approaches for delivery vehicles

The deadline for priority consideration is 29 March 2024.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:

To submit a podium presentation, please click here.
To become a sponsor, click here.
To present a poster, click here.

For more details on the conference, please contact:

Iris Goldman
Conference Producer
Cambridge Healthtech Institute
Phone: (+1) (781) 247-1814
Email: igoldman@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com